hotspot -WSS

hotspot

author：Wikipedia 2025-09-30 23:40:38 - browse：9

The experimental Alzheimer’s drug lecanemab, hailed after it slowed patients’ cognitive decline in a clinical trial, may have contributed to the death in June of a patient in the study, STAT has learned.

One investigator on the study flagged the death, noting it came after the patient experienced bleeding in the brain, and concluded it was related to the drug, according to documents obtained by STAT. Eisai, the drugmaker behind lecanemab, disagreed, pointing to other possible factors, including a series of setbacks in preceding months — multiple falls, a heart attack, a respiratory infection, and mini-stroke-like events.

Though still under investigation, the death suggests that new medicines to treat Alzheimer’s, like medicines to treat anything else, will come with their own side effects and costs. It also raises the importance of waiting for the full lecanemab data before drawing conclusions based on the positive press release put out by Eisai and its partner Biogen last month.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： 10 reasons why health care startups fail

knowledge

WSS

NIH confirmation hearing shows politicization of research

Syphilis numbers in the United States reach record heights

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

Pancreatic cancer early detection could be helped by AI

Boston competes with Raleigh

White House pharmacy plagued with problems, investigation finds

hotspot

hotspot

entertainment

In age of alternative facts, a scholarly course on calling out crap

Why Medicare shouldn’t cover every FDA

ChatGPT in medicine: STAT answers readers' burning questions

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

Medicare proposal to cover medical devices draws a mixed reaction

Medicare reduced heart disease by changing how it pays doctors

ChatGPT in medicine: STAT answers readers' burning questions

FTC sues over Novant Health acquisition of two N.C. hospitals

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Biogen walks away from Aduhelm, years after polarizing approval

Wikipedia

STAT Readout Newsletter: Today's biggest biotech updates

Merck, Johnson & Johnson CEOs will testify on high drug prices

Impact of Dobbs ruling felt at reproductive medicine meeting

Wegovy leads to weight loss. Can it treat depression, too?

Pharmacists can make shortage drugs, but at what cost?

Impact of Dobbs ruling felt at reproductive medicine meeting

knowledge

knowledge

entertainment

knowledge